| Basics |
Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases.
|
| IPO Date: |
November 9, 1984 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$263.91M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.19 | 3.56%
|
| Avg Daily Range (30 D): |
$0.15 | 3.15%
|
| Avg Daily Range (90 D): |
$0.13 | 2.38%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.77M |
| Avg Daily Volume (30 D): |
2.2M |
| Avg Daily Volume (90 D): |
1.28M |
| Trade Size |
| Avg Trade Size (Sh.): |
212 |
| Avg Trade Size (Sh.) (30 D): |
160 |
| Avg Trade Size (Sh.) (90 D): |
130 |
| Institutional Trades |
| Total Inst.Trades: |
402 |
| Avg Inst. Trade: |
$1.46M |
| Avg Inst. Trade (30 D): |
$3.31M |
| Avg Inst. Trade (90 D): |
$2.08M |
| Avg Inst. Trade Volume: |
.05M |
| Avg Inst. Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$1.76M |
| Avg Closing Trade (30 D): |
$.65M |
| Avg Closing Trade (90 D): |
$.65M |
| Avg Closing Volume: |
45.82K |
|
|
| Financials |
| |
TTM |
Q2 2025 |
Q1 2025 |
|
Basic EPS
|
$-.1
|
$2.07
|
$-.24
|
|
Diluted EPS
|
$-.1
|
$1.71
|
$-.24
|
|
Revenue
|
$ M
|
$ .4M
|
$ M
|
|
Gross Profit
|
$
|
$
|
$
|
|
Net Income / Loss
|
$ -5.16M
|
$ 108.83M
|
$ -12.03M
|
|
Operating Income / Loss
|
$ -24.02M
|
$ -22.79M
|
$ -19.73M
|
|
Cost of Revenue
|
$
|
$
|
$
|
|
Net Cash Flow
|
$ -80.65M
|
$ 147.6M
|
$ -7.42M
|
|
PE Ratio
|
|
|
|
| Splits |
|
Jul 05, 2022:
1:25
|
|
Oct 24, 2014:
1:50
|
|
Jun 05, 2006:
1:5
|
|
|
|
